Literature DB >> 12948526

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha.

Hong Ruan1, Harvey F Lodish.   

Abstract

Insulin resistance is a fundamental defect that precedes the development of the full insulin resistance syndrome as well as beta cell failure and type 2 diabetes. Tumor necrosis factor-alpha (TNF-alpha), a paracrine/autocrine factor highly expressed in adipose tissues of obese animals and human subjects, is implicated in the induction of insulin resistance seen in obesity and type 2 diabetes. Here, we review several molecular aspects of adipose tissue physiology, and highlight the direct effects of TNF-alpha on the functions of adipose tissue including induction of lipolysis, inhibition of insulin signaling, and alterations in expression of adipocyte important genes through activation of NF-kappaB, as well as their pertinence to insulin sensitivity of adipocytes. We also review the ability of TNF-alpha to inhibit synthesis of several adipocyte-specific proteins including Acrp30 (adiponectin) and enhance release of free fatty acids (FFAs) from adipose tissue, and discuss how these factors may act as systemic mediators of TNF-alpha and affect whole body energy homeostasis and overall insulin sensitivity. On the basis of these mechanisms, we examine the therapeutic potential of blocking specific autocrine/paracrine signaling pathways in adipocytes, particularly those involving NF-kappaB, in the treatment of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948526     DOI: 10.1016/s1359-6101(03)00052-2

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  115 in total

1.  An ironic tragedy: are spouses of persons with dementia at higher risk for dementia than spouses of persons without dementia?

Authors:  Peter P Vitaliano
Journal:  J Am Geriatr Soc       Date:  2010-05       Impact factor: 5.562

Review 2.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

3.  Decreased serum adiponectin in adolescents and young adults with familial primary hypercholesterolemia.

Authors:  Lian-Yu Lin; Chiau-Suong Liau; Wei-Shiung Yang; Ta-Chen Su
Journal:  Lipids       Date:  2005-02       Impact factor: 1.880

4.  Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C.

Authors:  S P Y Wong; M Huda; P English; A Bargiota; J P H Wilding; A Johnson; R Corrall; J H Pinkney
Journal:  Diabetologia       Date:  2005-11-17       Impact factor: 10.122

Review 5.  Cytokines and the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A M Diehl; Z P Li; H Z Lin; S Q Yang
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

Review 6.  Adipocyte, adipose tissue, and infectious disease.

Authors:  Mahalia S Desruisseaux; Maria E Trujillo; Herbert B Tanowitz; Philipp E Scherer
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

7.  Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.

Authors:  Carey N Lumeng; Stephanie M Deyoung; Alan R Saltiel
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-22       Impact factor: 4.310

Review 8.  Advanced-glycation end products in insulin-resistant states.

Authors:  Georgia Soldatos; Mark E Cooper; Karin A M Jandeleit-Dahm
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

9.  Peripheral tumor necrosis factor α regulation of adipose tissue metabolism and adipokine gene expression in neonatal pigs.

Authors:  T G Ramsay; M J Stoll; J A Conde-Aguilera; T J Caperna
Journal:  Vet Res Commun       Date:  2012-10-23       Impact factor: 2.459

Review 10.  Adiponectin in insulin resistance: lessons from translational research.

Authors:  Florencia Ziemke; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.